Three trials were published comparing reboxetine against other antidepressants in which reboxetine was just as good, and they were published, but three times as many patients' worth of data was collected which showed that reboxetine was worse than those other treatments, and those trials were not published.
Byly publikovány 3 studie srovnávající reboxetine s ostatními antidepresivy, ve kterých byl stejně dobrý, a ty byly otištěny, ale data od trojnásobného počtu pacientů naznačovala, že reboxetine je horší než ostatní léky, a tyto studie uveřejněny nebyly.